Genital Diseases, Female  >>  Zolinza (vorinostat)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zolinza (vorinostat) / Merck (MSD)
NCT00976183: Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma

Terminated
1/2
18
US
Vorinostat, suberoylanilide hydroxamic acid (SAHA)
Gynecologic Oncology Associates, Merck Sharp & Dohme LLC
Ovarian Neoplasms
06/12
10/12
NCT00910000: Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer

Terminated
1/2
15
US
Vorinostat, Zolinza, Carboplatin, paraplatin, Gemcitabine, Gemzar
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital, Merck Sharp & Dohme LLC
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
01/13
10/15

Download Options